本评估结果基于大数据模型，主要总结存在于女性中的一般规律，由于个体差异的存在，评估结果可能存在偏差。

预测未来女性生育力里程碑事件的发生年龄主要适用于月经规律的女性，对于月经不规律者，即月经周期大于 35 天或者小于 21 天，预测结果的参考价值降低。

卵巢储备减退年龄（DOR年龄）是指根据平均女性卵巢衰老速度预测的卵巢储备评分达到 50 分时的年龄，即卵巢储备 D 级开始的年龄。

OvaRePred评估工具是基于Anshlab AMH结果计算得到的，其他检测平台得到的AMH数值需要与Anshlab平台AMH数值进行变换后方可使用。

本次报告仅供参考，不建议作为医疗诊断使用，卵巢储备相关具体医学问题请咨询临床医生。

1.Huiyu Xu, Guoshuang Feng, Rui Yang, Rong Li, Jie Qiao. (2023) OvaRePred: Online tool for predicting the age of fertility milestones. The Innovation 2023 4(5): 100490 IF=33.1

2.Huiyu Xu*, Li Shi*, Guoshuang Feng*, Zhen Xiao, Lixue Chen, Rong Li, Jie Qiao. An Ovarian Reserve Assessment Model Based on Anti-Mullerian Hormone Levels, Follicle-Stimulating Hormone Levels, and Age: Retrospective Cohort Study. JMIR 2020 22; e19096 IF=5.428

3.Huiyu Xu*, Guoshuang Feng*, Haiyan Wang*, Yong Han, Rui Yang, Ying Song, Lixue Chen, Li Shi, Mengqian Zhang, Rong Li, Jie Qiao. A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study. Journal of assisted Reproduction and Genetics 2020 37:963-972. IF=3.412

4.Yong Han*, Huiyu Xu (co-first), Guoshuang Feng*, Haiyan Wang, Yong Han, Kannan Alpadi, Lixue Chen, Mengqian Zhang, Rong Li, and Jie Qiao. An online tool for predicting ovarian reserve based on AMH level and age: A retrospective cohort study. Frontiers in endocrinology 2022. 13:946123 IF=6.055

5.Huiyu Xu, Wei Wang, Yong Han, Rong Li, and Jie Qiao. OvaRePred: Redefing ovarian aging and pioneering the journey towards women's health management. The Innovation. The Innovation Medicine 2(2): 100068

6.Tao Huang, Huiyu Xu (co-first), Haitao Wang, Yongjun Xu, Baohua Li, Shenda Hong, Guoshuang Feng, Shuyi Kui, Guangjian Liu, Dehua Jiang, Zhicheng Li, Ye Li, Congcong Ma, Chunyan Su, Wei Wang, Rong Li, Puxiang Lai, Jie Qiao. (2023) Artificial intelligence for medicine: Progress, challenges, and perspectives The Innovation Medicine 1(2): 100030

7.Huiyu Xu*, Mengqian Zhang*, Hongxian Zhang*, Kannan Alpadi, Lina Wang, Rong Li, Jie Qiao. Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update. The Innovation 2021 2:100091.